Further exploration of cell-type-specific hepatic HAS enzyme expression, hepatic HA accumulation, and hepatic HA molecular weight distribution during liver disease pathogenesis, progression, or resolution is required to understand the differences between our study and the other studies discussed above. This evidence concerns the gene HAS1 and liver disorder.